OrganiGram Holdings Correlations
OGI Stock | USD 1.51 0.03 2.03% |
The current 90-days correlation between OrganiGram Holdings and Cronos Group is 0.69 (i.e., Poor diversification). The correlation of OrganiGram Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
OrganiGram Holdings Correlation With Market
Significant diversification
The correlation between OrganiGram Holdings and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding OrganiGram Holdings and DJI in the same portfolio, assuming nothing else is changed.
OrganiGram |
Moving together with OrganiGram Stock
0.67 | ME | 23Andme Holding | PairCorr |
0.81 | VALN | Valneva SE ADR Downward Rally | PairCorr |
0.73 | DRMA | Dermata Therapeutics | PairCorr |
0.74 | DRRX | Durect | PairCorr |
0.69 | DTIL | Precision BioSciences | PairCorr |
0.64 | VINC | Vincerx Pharma | PairCorr |
0.85 | VIRX | Viracta Therapeutics | PairCorr |
0.81 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.78 | VTGN | VistaGen Therapeutics | PairCorr |
0.81 | EDIT | Editas Medicine | PairCorr |
0.72 | EDSA | Edesa Biotech Fiscal Year End 20th of December 2024 | PairCorr |
0.87 | VXRT | Vaxart Inc | PairCorr |
Moving against OrganiGram Stock
0.58 | VERA | Vera Therapeutics | PairCorr |
0.56 | SABSW | SAB Biotherapeutics | PairCorr |
0.5 | DVAX | Dynavax Technologies | PairCorr |
0.46 | DSGN | Design Therapeutics | PairCorr |
0.42 | DRUG | Bright Minds Biosciences | PairCorr |
0.39 | VCEL | Vericel Corp Ord | PairCorr |
0.37 | VRDN | Viridian Therapeutics | PairCorr |
0.69 | VSTM | Verastem | PairCorr |
0.66 | VTRS | Viatris | PairCorr |
0.65 | VRNA | Verona Pharma PLC | PairCorr |
0.6 | ELTX | Elicio Therapeutics | PairCorr |
0.53 | VYNE | Vyne Therapeutics | PairCorr |
0.48 | ELDN | Eledon Pharmaceuticals | PairCorr |
0.41 | ENSC | Ensysce Biosciences | PairCorr |
0.36 | ELVN | Enliven Therapeutics | PairCorr |
Related Correlations Analysis
0.79 | 0.43 | 0.73 | 0.47 | 0.54 | 0.8 | CRON | ||
0.79 | 0.52 | 0.85 | 0.55 | 0.8 | 0.95 | ACB | ||
0.43 | 0.52 | 0.58 | -0.22 | 0.45 | 0.51 | SNDL | ||
0.73 | 0.85 | 0.58 | 0.23 | 0.59 | 0.81 | CGC | ||
0.47 | 0.55 | -0.22 | 0.23 | 0.56 | 0.57 | HEXO | ||
0.54 | 0.8 | 0.45 | 0.59 | 0.56 | 0.74 | CURLF | ||
0.8 | 0.95 | 0.51 | 0.81 | 0.57 | 0.74 | TLRY | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between OrganiGram Stock performing well and OrganiGram Holdings Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze OrganiGram Holdings' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CRON | 2.16 | (0.19) | 0.00 | 0.98 | 0.00 | 4.74 | 19.33 | |||
ACB | 2.64 | (0.54) | 0.00 | 16.56 | 0.00 | 5.51 | 26.91 | |||
SNDL | 2.05 | (0.06) | 0.00 | 0.34 | 0.00 | 3.86 | 24.46 | |||
CGC | 3.45 | (0.60) | 0.00 | 0.74 | 0.00 | 8.26 | 35.86 | |||
HEXO | 3.85 | (0.83) | 0.00 | (0.50) | 0.00 | 5.88 | 56.99 | |||
CURLF | 4.04 | (0.49) | 0.00 | (10.20) | 0.00 | 9.51 | 43.19 | |||
TLRY | 2.22 | (0.48) | 0.00 | 1.01 | 0.00 | 4.94 | 21.22 |
OrganiGram Holdings Corporate Management
CPA CPA | Chief Officer | Profile | |
Beena Goldenberg | CEO Director | Profile | |
Helen Martin | Chief Secretary | Profile | |
Katrina McFadden | Chief Officer | Profile | |
Megan McCrae | Senior Communications | Profile | |
Amy Schwalm | VP Relations | Profile | |
CFA CA | Chief Officer | Profile |